Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation
Citations Over TimeTop 10% of 2015 papers
Abstract
Gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid (Gd-EOB-DTPA) is a hepatocyte-specific MRI contrast agent. Because the hepatic uptake of Gd-EOB-DTPA depends on the integrity of the hepatocyte mass, this uptake can be quantified to assess liver function. We report the relationship between the extent of Gd-EOB-DTPA uptake and the degree of liver fibrosis. T1-weighted volume-interpolated breath-hold examination (VIBE) sequences with fat suppression were acquired before and 20 minutes after contrast injection. Strong correlations of the uptake characteristics of Gd-EOB-DTPA with the relative enhancement (RE) of the liver parenchyma and the grade of fibrosis/cirrhosis, classified using the Ishak scoring system, were observed. The subdivisions between the grades of liver fibrosis based on RE were highly significant for all combinations, and a ROC revealed sensitivities ≥82% and specificities ≥87% for all combinations. MR imaging is a satisfactorily sensitive method for the assessment of liver fibrosis/cirrhosis.
Related Papers
- → Gadolinium Retention in the Rat Brain: Assessment of the Amounts of Insoluble Gadolinium-containing Species and Intact Gadolinium Complexes after Repeated Administration of Gadolinium-based Contrast Agents(2017)110 cited
- → Gadolinium-based contrast agents: From gadolinium complexes to colloidal systems(2019)46 cited
- → Elemental Imaging of Long-term Gadolinium Retention in Rodent Femur(2022)7 cited
- → Gadolinium(III) 3,5,5-trimethylhexanoate complexes for creation of stable Gd-loaded liquid organic scintillators(2016)9 cited
- → Experimental study on intracranial gadolinium deposition in rats after linear conversion to macrocyclic gadolinium contrast agent(2023)